Expert Opinion on Biological Therapy

Expert Opinion on Biological Therapy is a monthly peer-reviewed journal published by Taylor & Francis, established in 2001, covering biological therapies including antibodies, vaccines, gene and cell therapies, with a 2025 impact factor of 4.0（Expert Opinion on Biological Therapy）是由（Taylor & Francis）出版的月刊，2001 年创刊，涵盖抗体、疫苗、基因与细胞治疗等生物疗法，2025 年影响因子为 4.0。

Scope

• It publishes review articles and original papers on all aspects of biological therapy该刊刊载生物治疗各领域的综述与原创论文。
• Key areas include therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer, and cell-based therapies and regenerative medicine重点领域包括治疗性抗体与疫苗、多肽与蛋白质、基因治疗与基因转移，以及细胞治疗与再生医学。
• It also publishes drug evaluations reviewing the clinical data on a particular biological agent该刊还发表针对某一生物制剂临床数据的药物评价。
• Each review includes an Expert Opinion section giving the author's personal view alongside a summarised Article Highlights box每篇综述均设「专家观点」栏目以呈现作者个人见解，并附「文章要点」摘要。
• The journal does not publish case reports or case series, and letters must discuss previously published articles该刊不发表病例报告或病例系列，来信须讨论已发表的文章。

History

• The journal was established in 2001 and is part of the Taylor & Francis Expert Opinion series该刊 2001 年创刊，隶属（Taylor & Francis）的「专家观点」系列。
• It appears in twelve issues a year and is indexed in MEDLINE and EMBASE该刊每年出版 12 期，被 MEDLINE 与 EMBASE 收录。
• It was originally published under the Informa Healthcare imprint before becoming part of Taylor & Francis该刊早期以（Informa Healthcare）品牌出版，后并入（Taylor & Francis）。
• Its 2025 impact factor is 4.0, with a five-year impact factor of 4.1其 2025 年影响因子为 4.0，五年影响因子为 4.1。

Editors

• The editor-in-chief is Thomas Ciulla of Indiana University School of Medicine, USA现任主编为（Indiana University School of Medicine）的 Thomas Ciulla。
• Michael Morse of Duke University Medical Center serves as editor-in-chief emeritus（Duke University Medical Center）的 Michael Morse 任荣休主编。
• The editorial board is international and organised by specialty, covering allergy, dermatology, endocrinology, haematology, neurology, oncology, ophthalmology, regenerative medicine and rheumatology编委会具国际性并按学科分组，涵盖变态反应、皮肤科、内分泌、血液、神经、肿瘤、眼科、再生医学与风湿病学。
• Manuscripts are double-anonymously peer reviewed, and pre-submission enquiries go to the commissioning editor稿件实行双向匿名评审，投稿前咨询请联系组稿编辑。